Ernexa Therapeutics Inc.
ERNA
$4.27
-$0.03-0.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.19% | -266.58% | -21.03% | 60.47% | 61.73% |
| Total Depreciation and Amortization | -48.84% | 24.64% | -1.43% | 27.27% | -20.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.63% | 631.04% | 188.16% | -137.51% | -82.79% |
| Change in Net Operating Assets | -169.31% | 1,514.00% | -117.92% | 160.52% | -354.70% |
| Cash from Operations | -83.39% | -97.21% | 9.75% | 49.76% | -22.62% |
| Capital Expenditure | -50.00% | 86.67% | 31.82% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.00% | 86.67% | 31.82% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.94% | -- | -100.00% | -99.47% | 123,125.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -- | -- | -- |
| Cash from Financing | -99.94% | -- | -100.00% | -99.47% | 118.68% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -156.89% | 727.09% | 8.28% | -152.90% | 1,168.25% |